21.04.2020 Views

Annual-Report-2019

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Dr Eric Robert

CONSORTIUM COORDINATOR

ARD 2020 COSMÉTOSCIENCES

Eric ROBERT is a CNRS senior Scientist at GREMI laboratory, Orléans, France. He has been involved in the development,

diagnostics and applications of gas discharge plasmas for light source, micro electronics, X-rays diagnostics, and from

ten years in the biomedical technologies. His recent publications concern the physics of plasma jets, the antitumour

action of atmospheric pressure cold plasma jets, the combination of plasma treatment with electrochemotherapy, the

use of plasmas for skin treatment in anti-aging strategies. He is assistant director of the GREMI laboratory, in charge of

the «plasma for biomedical applications» team, and director of the French network «HAPPYBIO» gathering fourty teams

connected with the researches on the use of plasmas, pulsed electric field and dynamic phototherapy for biology. He is

a board member of the International Society for Plasma Medicine and of the International Plasma Chemistry Society.

He was the awardee of the Cosmetic Victories in 2017 for the development of cold plasma technology for cosmetics.

PLASMA COSMETIC CONSORTIUM

The “Plasma Cosmetic Consortium” (PCC) consits in an interdisciplinary team gathering plasma physicists, skin

biologists, chemical and biomolecular engineers, pharmacists, electronicians and pulse power engineers all previously

involved in “Plasma Medicine”. Plasma medicine targets the development of innovative therapeutics for challenging

diseases where gas discharges have recently shown to offer tremendous opportunities alone or in combination with

more conventional treatments.

Life & Health Sciences 2019

62

The main objective of the PCC is to assess the potentialities of cold plama technology, i.e gas discharges in ambient air

at atmospheric pressure and at temperature lower than 40°C, for cosmetic industry.

One first challenge was to have a clear vision of the very broad needs and market of cosmetics industry, ranging

from skin/nails/hair care, cosmetic products extraction/formulation and packaging. Then the aim was to translate

the achievements from Plasma Medicine (specially from plasma dermatology) and plasma technology to Cosmetics.

Another objective is to reach safe, non toxic plasma approach offering a new physical vector (such as ultrason, light,

mechanical stimulation) for skin care. In this perspective, dedicated plasma applicators, meeting consumers demand,

skin tissue models allowing the evaluation of plasma application for skin care (of course banning animal testing), and

innovative plasma-assisted production of cosmetic products and packaging have to be addressed. The PCC consortium

was formed to answer the all constraints and taking into account all positive assets: the French industrial leadership,

the unique status of the Centre Val De Loire region, the Cosmetic Valley network, and the worldwide and continuously

increasing market. PPC is working on establishing an international conference focusing on the science and technology

of plasma for cosmetics, initiating a new branch of cold plasma technology for biomedical/biological applications

and building up and strengthening an international community focused on research and innovation for sustainable,

environmentally and user-friendly cosmetic industry.

So far, the international consortium was shaped, met two times and experienced numbers of exchanges to define the

list of topics correlated with Plasma Cosmetics, organized the First International Meeting on Plasma Cosmetic Science

(IMPCS-1) in Orleans in November 2019, initiated the writing of an opinion paper on “opportunities for plasma-inspired

innovation in cosmetic biotechnology”, reached a first consensus on the definition of the “Plasma Cosmetic Science”

asside other plasma aesthetics approaches based on “hot plasmas” or laser tools, and launched the organisation of

IMPCS-2 in Japan in 2021.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!